INTERNATIONAL BIOTECHNOLOGY TRUST PLC - UNIQURE NV ownership

UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 160 filers reported holding UNIQURE NV in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
INTERNATIONAL BIOTECHNOLOGY TRUST PLC ownership history of UNIQURE NV
ValueSharesWeighting
Q3 2023$8,330,465
+4589.8%
1,241,500
+7909.7%
2.81%
+5096.3%
Q2 2023$177,630
-98.2%
15,500
-96.8%
0.05%
-98.0%
Q1 2023$9,636,990
-32.6%
478,500
-24.2%
2.69%
-39.1%
Q4 2022$14,297,160
+40.0%
631,500
+16.0%
4.42%
+34.9%
Q3 2022$10,209,000
-97.7%
544,500
+6446.0%
3.27%
-29.7%
Q2 2022$446,500,000
+3682.9%
8,318
-94.7%
4.66%
+75.0%
Q1 2022$11,803,000
+266.0%
155,5000.0%2.66%
+270.8%
Q4 2021$3,225,000
-44.7%
155,500
-14.7%
0.72%
-49.0%
Q3 2021$5,834,000
-39.9%
182,194
-42.3%
1.41%
-45.1%
Q2 2021$9,705,000
+2.3%
315,500
+11.9%
2.56%
+2.1%
Q1 2021$9,490,000
+854.7%
282,034
+925.6%
2.51%
+826.2%
Q4 2020$994,000
-1.9%
27,5000.0%0.27%
-17.1%
Q3 2020$1,013,000
-19.4%
27,5000.0%0.33%
-21.8%
Q2 2020$1,257,000
-2.5%
27,5000.0%0.42%
-28.9%
Q1 2020$1,289,000
+33.3%
27,500
+103.7%
0.59%
+69.0%
Q4 2019$967,000
-10.6%
13,500
-50.9%
0.35%
-30.4%
Q3 2019$1,082,000
-49.6%
27,5000.0%0.50%
-37.2%
Q2 2019$2,147,00027,5000.80%
Other shareholders
UNIQURE NV shareholders Q3 2023
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 155,500$11,803,0002.66%
Aquilo Capital Management, LLC 901,490$16,290,0002.39%
Nantahala Capital Management 2,811,459$50,803,0002.25%
Privium Fund Management B.V. 493,229$8,913,0001.97%
683 Capital Management, LLC 1,355,000$24,485,0001.31%
Henry James International Management Inc. 125,622$2,270,0000.90%
Integral Health Asset Management, LLC 170,000$3,072,0000.80%
Nantahala Capital Management 890,000$16,082,0000.71%
Sonic Fund II, L.P. 50,000$904,0000.51%
Voss Capital, LLC 70,000$1,265,0000.40%
View complete list of UNIQURE NV shareholders